OMDA
Omada HealthNASDAQHealthcare$12.58-0.24%ClosedMarket Cap: $741.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.20
P/S
2.85
EV/EBITDA
-80.11
DCF Value
$-14.36
FCF Yield
2.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.5%
Operating Margin
-4.6%
Net Margin
-4.9%
ROE
-7.1%
ROA
-4.4%
ROIC
-5.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $75.8M | 70.3% | $3.3M | $5.2M | $0.09 | — |
| FY 2025 | $260.2M | 65.5% | $-12.0M | $-12.8M | $-0.22 | — |
| Q3 2025 | $68.0M | 66.3% | $-2.5M | $-3.2M | $-0.05 | — |
| Q2 2025 | $61.4M | 65.5% | $-4.3M | $-5.3M | $-0.09 | — |
| Q1 2025 | $55.0M | 58.0% | $-8.4M | $-9.4M | $-0.17 | — |
| Q4 2024 | $48.0M | 66.6% | $-7.1M | $-8.2M | $-0.15 | — |
| FY 2024 | $169.8M | 60.6% | $-43.7M | $-47.1M | $-0.85 | — |
| Q3 2024 | $45.5M | 62.4% | $-8.5M | $-9.2M | $-0.17 | — |
| Q2 2024 | $41.2M | 59.9% | $-10.0M | $-10.7M | $-0.19 | — |
| Q1 2024 | $35.1M | 49.4% | $-18.0M | $-19.0M | $-0.34 | — |
| Q4 2023 | $32.5M | 61.7% | $-13.4M | $-13.9M | $-0.25 | — |
| FY 2023 | $122.8M | 57.0% | $-66.0M | $-67.5M | $-1.21 | — |